Day 0 - April 6, 2027 - Western European Summer Time (WEST)
A unique, powerful and valuable space for the candid sharing of experience between 20-25 of the sector's emerging and early-stage biotech senior executives. Like-minded founders and CEOs are joined by appropriate and value-matched industry stakeholders and partners to provide expertise, experience and best practice on strategic areas of focus. Case studies will also be delivered by those who have enjoyed success or navigated key challenges in their pursuit of early-stage company growth.
The qualifying criteria of this session is participants must be a CEO, Founder, Co-Founder or President of an early-stage, pre-revenue or early-revenue Biotech company.
A unique, powerful and valuable space for the candid sharing of experience between 20-25 of the sector's established growth-stage, biotech senior executives. Like-minded executives are joined by appropriate and value-matched industry stakeholders and partners to provide expertise, experience and best practice on strategic areas of focus. Case studies will also be delivered by those who have enjoyed success or navigated key challenges in their pursuit of company growth.The qualifying criteria of this session is participants must be a CEO, Founder, Co-Founder or President of a revenue-generating, Biotech company.
Unlock new possibilities for accessing the US public markets, and in particular, US Nasdaq. Join Mintz for a workshop exploring innovative routes beyond the conventional IPO. Gain valuable insights into alternative strategies to fuel your company's growth and expansion.
- Explore strategic alternatives to the traditional IPO process
- Learn how to navigate different pathways to the US public market
- Understand how these routes can help you achieve your financial objectives
- Gain valuable knowledge for your company's public market journey